Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Keloid excision with intra-operative triamcinolone versus triamcinolone + platelet-rich plasma
TCTR20250501004Phase 2Not yet recruiting
- Sponsor
- Chanokchon Kongkergkiat, M.D.
- Start
- Apr 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of triamcinolone acetonide in keloid (2 arms), sponsored by Chanokchon Kongkergkiat, M.D. Primary endpoint: Recurrence rate of keloid. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
triamcinolone acetonide
03
Conditions
keloid
Beyond the preview
Go deeper on TCTR20250501004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250501004.